Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The ability to adapt to a dynamic world relies on detecting, learning, and responding to environmental changes. The detection of novelty serves as a critical indicator of such changes, priming mechanisms to detect and respond to goal-relevant information. However, neural regions that support novelty detection (hippocampus) and goal-directed behavior (dopaminergic midbrain [VTA] and prefrontal cortex [PFC]) have yet to be described as a sequential process that unfolds over time. Using a forward-prediction functional magnetic resonance imaging (fMRI) model, we explored interactions between the hippocampus, VTA, and PFC in humans performing a novelty-imbued target-detection task. Hippocampal novelty activation predicted subsequent VTA target activation, enhancing readiness to detect goal-relevant information. Concurrently, goal-directed PFC activation modulated VTA target activation, refining focus on behaviorally significant cues. These circuits function both synergistically and independently, promoting subsequent hippocampal activity during target trials. This work provides new insights into how distributed circuits coordinate to optimize adaptive behavior.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12393253PMC
http://dx.doi.org/10.1101/2024.12.16.628816DOI Listing

Publication Analysis

Top Keywords

vta target
8
target activation
8
prior novelty
4
novelty invigorates
4
invigorates future
4
future mesolimbic
4
target
4
mesolimbic target
4
target detection
4
detection ability
4

Similar Publications

Whole-brain mapping of afferent and efferent connections of lateral hypothalamic orexinergic neurons in mice.

Brain Res

September 2025

Neuroscience Laboratory for Cognitive and Developmental Disorders, Department of Anatomy, Medical College of Jinan University, Guangzhou 510632, China. Electronic address:

Orexin (Orx) is a vital peptide neurotransmitter essential for regulating feeding, sleep-wake cycles, and reward-seeking behavior. Orexinergic neurons are predominantly located in the lateral hypothalamus (LH). However, the precise neural connectivity of these neurons across the brain remains insufficiently characterized.

View Article and Find Full Text PDF

The ability to adapt to a dynamic world relies on detecting, learning, and responding to environmental changes. The detection of novelty serves as a critical indicator of such changes, priming mechanisms to detect and respond to goal-relevant information. However, neural regions that support novelty detection (hippocampus) and goal-directed behavior (dopaminergic midbrain [VTA] and prefrontal cortex [PFC]) have yet to be described as a sequential process that unfolds over time.

View Article and Find Full Text PDF

Objective: Neuroimaging studies have independently associated schizophrenia with low iron and elevated dopamine synthesis. While preclinical research demonstrates that midbrain iron deficiency leads to striatal hyperdopaminergia, this relationship has not been studied in schizophrenia. The authors conducted a case-control study to examine differences in tissue magnetic susceptibility, a marker of brain iron, and correlated these with striatal dopamine synthesis capacity.

View Article and Find Full Text PDF

Substance use disorders (SUDs) remain a major public health challenge, with existing pharmacotherapies offering limited long-term efficacy. Traditional treatments focus on dopaminergic systems but often overlook the complex interplay between metabolic signals, neuroplasticity, and conditioned behaviors that perpetuate addiction. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for type 2 diabetes and obesity, have recently emerged as promising modulators of reward-related brain circuits.

View Article and Find Full Text PDF

Gene therapy offers a promising treatment for Leber's hereditary optic neuropathy (LHON), a disease of retinal ganglion cell (RGC) degeneration with severe vision loss caused by mitochondria-NADH dehydrogenase 4 (MT-ND4) mutations. However, optimizing mitochondria-targeted gene delivery to promote RGC regeneration and visual-photoreception recovery remains challenging in LHON. Here, mitochondria-targeted wireless charging gold nanoparticles (WCGs), doubling as a wireless charging-mediated gene-delivery platform and electric stimulus-restored phototransduction, are developed for LHON treatment.

View Article and Find Full Text PDF